Guardant Health, Inc. (BMV:GH)

DFS Statistics

Total Valuation

Guardant Health has a market cap or net worth of MXN 125.34 billion. The enterprise value is 140.38 billion.

Market Cap	125.34B
Enterprise Value	140.38B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	123.89M
Shares Outstanding	n/a
Shares Change (YoY)	+2.95%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	119.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.02
PB Ratio	-21.76
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.99
EV / Sales	9.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.40

Financial Position

The company has a current ratio of 3.71

Current Ratio	3.71
Quick Ratio	2.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-4.91
Interest Coverage	-150.23

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-19.57%
Return on Invested Capital (ROIC)	-24.30%
Return on Capital Employed (ROCE)	-42.10%
Revenue Per Employee	7.78M
Profits Per Employee	-3.88M
Employee Count	2,021
Asset Turnover	0.56
Inventory Turnover	4.08

Taxes

In the past 12 months, Guardant Health has paid 20.25 million in taxes.

Income Tax	20.25M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +157.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+157.53%
50-Day Moving Average	1,333.61
200-Day Moving Average	n/a
Relative Strength Index (RSI)	51.51
Average Volume (20 Days)	1,682

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.11

Income Statement

In the last 12 months, Guardant Health had revenue of MXN 15.63 billion and -7.80 billion in losses. Loss per share was -63.09.

Revenue	15.63B
Gross Profit	9.82B
Operating Income	-8.68B
Pretax Income	-7.78B
Net Income	-7.80B
EBITDA	-7.90B
EBIT	-8.68B
Loss Per Share	-63.09

Balance Sheet

The company has 9.86 billion in cash and 25.16 billion in debt, giving a net cash position of -15.30 billion.

Cash & Cash Equivalents	9.86B
Total Debt	25.16B
Net Cash	-15.30B
Net Cash Per Share	n/a
Equity (Book Value)	-5.76B
Book Value Per Share	-46.28
Working Capital	12.16B

Cash Flow

In the last 12 months, operating cash flow was -4.50 billion and capital expenditures -625.75 million, giving a free cash flow of -5.12 billion.

Operating Cash Flow	-4.50B
Capital Expenditures	-625.75M
Free Cash Flow	-5.12B
FCF Per Share	n/a

Margins

Gross margin is 62.84%, with operating and profit margins of -55.55% and -49.93%.

Gross Margin	62.84%
Operating Margin	-55.55%
Pretax Margin	-49.80%
Profit Margin	-49.93%
EBITDA Margin	-50.57%
EBIT Margin	-55.55%
FCF Margin	n/a

Dividends & Yields

Guardant Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.95%
Shareholder Yield	n/a
Earnings Yield	-6.23%
FCF Yield	-4.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guardant Health has an Altman Z-Score of -1.23 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.23
Piotroski F-Score	4